CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

NARecruitingINTERVENTIONAL
Enrollment

5,800

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Venous Thromboembolic DiseasePulmonary EmbolismVenous ThromboembolismDeep Venous ThrombosisQuality Improvement
Interventions
OTHER

The multifaceted interventions

"1. An evidence-based clinical guideline and pathway in hospital.~2. A series Written care protocols for the implementation of performance measures.~3. A newly developed mobile application (mini-program) will be employed to facilitate venous thromboembolism (VTE) risk assessment and prophylaxis. Patients will scan a QR code to enroll in the program and be linked with their physician. Through the application, patients will complete standardized self-assessments of VTE risk, and physicians will receive periodic reminders indicating whether the assessment and prophylaxis orders have been completed.The application also provides educational modules and targeted messages for both patients and physicians, and enables interactive communication.~4. A quality-control team will receive weekly feedback reports to verify whether all enrolled patients underwent appropriate prophylaxis."

OTHER

Routine VTE prophylaxis

Patients randomized to the Routine VTE prophylaxis (Control) group will receive routine VTE prophylaxis according to current guidelines and clinical practices

Trial Locations (1)

100029

RECRUITING

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

China-Japan Friendship Hospital

OTHER

NCT04211181 - CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism | Biotech Hunter | Biotech Hunter